FBLG
FibroBiologics, Inc.
Healthcare • CIK: 0001958777
Loading...
Market Cap
$10.05M
P/E (TTM)
-0.5x
Rev Growth (TTM)
—
Net Margin (TTM)
—
FCF Yield (TTM)
-165.8%
FCF Margin (TTM)
0.0%
LATEST EARNINGS
No earnings in last 90 days
Check back after next 8-K filing
Cash Flow Health
Free Cash Flow0/8 positive
TTM$-17M
FCF Margin
TTM0.0%
Sector: 0.0%Below Avg
OCF Margin–
OCF/NI0.88x
CapEx Coverage-62.6x
FCF Yield-165.8%
FCF Growth (2Y)–
Cash Conversion Cycle
–
Capital Allocation & Returns
Total Shareholder Yield
TTM0.0%
Div Yield0.0%
Insufficient data
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$-16.7M
Capital Return / FCF0.0%
Est. Dividends Paid (TTM)$0
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
-480.9%
Volatile
+12.6% YoY+30313.8%
P25MedianP75
25th pctl (med: 0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
–
Asset Turnover
0.00x
8Q: 0.00x
Leverage (1+D/E)
1.00x
D/E: 0.00x
Asset & CapEx Efficiency
CapEx Intensity
7.6%
8Q:4.2%
CapEx/Depreciation
1.07x
Asset-based ROIC formula
QUARTERLY TRENDS
No data available
Valuation Analysis
Fair Value
Price-to-EarningsTTM
-0.5x
Volatile
8Q: -7.0x+2519%
Valuation Lenses
Earnings
-0.5x
vs – sector
Cash Flow
-0.1x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
–P/E per %ROIC
ROIC: -480.9%
Shareholder Returns
Dividend
–
Buyback
–
Total Yield
–
Market Cap$10.05M
EV$2.09M
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
-1413/100
Below Average
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Top 10%
-9.6%
8Q:–
Return on Invested Capital (ROIC)Below Avg
-4.8%
8Q:–
+30313.8%
Earnings Quality
Cash Conversion
0.88x
OCF / Net Income
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin–
Capital Efficiency
Invested Capital Turnover–
Working Capital
Cash Conversion Cycle–
Growth Quality & Momentum
Growth Rates
Revenue Growth YoY
N/A
OpInc Growth YoY
N/A
EPS Growth YoY
-23.5%
FCF 3Y CAGR
N/A
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
—
Operating
—
Net
—
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
—
FCF: 0.0% | Net: —
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Fortress
Net Debt / EBITDA
Net Cash
(0.0x)Net Cash: $4.89M
Interest Coverage
–
+Net cash position: $4.89M
Leverage Metrics
Debt-to-Equity
0.00x
Balance sheet risk & solvency analysis